X. Du et al. / Tetrahedron: Asymmetry 21 (2010) 241–246
245
(300 MHz, CDCl3): d = 7.76 (d, J = 6.9 Hz, 2H), 7.21–7.33 (m, 16H),
4.49–4.59 (m, 2H), 4.24 (t, J = 9.0 Hz, 2H), 4.02 (t, J = 7.8 Hz, 2H),
3.14 (dd, J1 = 13.8 Hz, J2 = 5.4 Hz, 2H), 2.59 (dd, J1 = 13.8 Hz,
J2 = 8.4 Hz, 2H). 13C NMR (75 MHz, CDCl3): d = 163.4, 138.0, 137.2,
132.5, 131.0, 130.4, 129.3, 128.4, 126.6, 126.4, 71.7, 68.2, 41.7. IR
(neat): 3060, 2917, 2849, 1648, 1587, 1495, 1475, 1453, 1435,
J = 7.2 Hz, 2H), 3.96 (q, J = 7.2 Hz, 2H), 3.92 (d, J = 9.0 Hz, 1H),
1.20 (t, J = 7.2 Hz, 3H), 1.00 (t, J = 7.2 Hz, 3H). 13C NMR (75 MHz,
CDCl3): d = 167.8, 167.3, 140.3, 136.8, 131.6, 129.3, 128.6, 128.4,
127.9, 127.4, 127.0, 126.3, 61.5, 61.3, 57.7, 49.2, 14.0, 13.7.
4.7.2. (S)-Dimethyl 2-[(E)-1,3-diphenylprop-2-en-1-yl]malonate
12
1355, 1286, 1245, 1139, 1093, 1030, 962, 910, 769, 732 cmꢂ1
.
HR-ESIMS: m/z cacld for C32H29N2O2S (M+H): 505.19497. Found:
505.19335.
Prepared according to the general procedure using (E)-1,3-
diphenylprop-2-en-1-yl acetate (0.126 g, 0.50 mmol), while the
reaction time was 48 h. The desired product was obtained as a col-
orless oil (149 mg, 84% yield). The ee was determined by chiral
HPLC on Daicel Chiralpak IA column (n-hexane–isopropanol
90:10 V/V, 0.5 mL/min, 254 nm, tminor = 15.7 min, tmajor = 19 min).
4.6.3. 2,20-Bis[(S)-4-isopropyloxazolin-2-yl]-1,10-diphenyl-
sulfide 1c
Prepared according to the general procedure using 0.713 g
(1.60 mmol) 8c. The desired ligand was obtained as a colorless
½
a 2D0
ꢁ
¼ ꢂ10:7 (c 0.7 g/100 mL, CH2Cl2, 89% ee). {Lit.18
oil (0.472 g, 73% yield). ½a D20
ꢁ
¼ ꢂ22:2 (c 0.6, CH2Cl2). 1H NMR
½
a 2D0
ꢁ
¼ ꢂ11:2 (c 1.04, CHCl3) 86% ee}, 1H NMR (300 MHz, CDCl3):
(300 MHz, CDCl3): d = 7.74 (d, J = 6.9 Hz, 2H), 7.24–7.33 (m, 6H),
4.25–4.34 (m, 2H), 4.00–4.10 (m, 4H), 1.70–1.80 (m, 2H), 0.96 (d,
J = 6.3 Hz, 6H), 0.89 (d, J = 6.3 Hz, 6H). 13C NMR (75 MHz, CDCl3):
d = 162.8, 137.2, 132.5, 130.8, 130.2, 129.5, 126.5, 73.0, 70.1, 32.8,
18.7, 18.3. IR (neat): 2958, 2900, 2872, 1650, 1588, 1560, 1468,
d = 7.19–7.30 (m, 10H), 6.48 (d, J = 15.6 Hz, 1H), 6.33 (dd,
J1 = 15.6 Hz, J2 = 8.4 Hz, 1H), 4.27 (dd, J1 = 10.8 Hz, J2 = 8.4 Hz, 1H),
3.96 (d, J = 10.8 Hz, 1H), 3.69 (s, 3H), 3.51 (s, 3H). 13C NMR
(75 MHz, CDCl3): d = 168.1, 167.7, 140.1, 136.8, 131.8, 129.1,
128.7, 128.4, 127.8, 127.5, 127.1, 126.3, 57.6, 52.6, 52.4, 49.1.
1436, 1352, 1307, 1242, 1139, 1093, 1037, 963, 905, 767 cmꢂ1
.
HR-ESIMS: m/z cacld for C24H29N2O2S (M+H): 409.19497. Found:
409.19394.
4.7.3. (S)-1,3-Dimethyl-5-[(E)-1,3-diphenylprop-2-en-1-
yl]barbituric acid 13
Prepared according to the general procedure using (E)-1,3-
diphenylprop-2-en-1-yl acetate (0.126 g, 0.50 mmol), while the
reaction time was prolonged to 5 days; the desired product was
obtained as a light yellowish solid (127 mg, 73% yield). Mp 113–
114 °C. The ee was determined by chiral HPLC on Daicel Chiralpak
AS-H column (n-hexane–isopropanol 80:20 V/V, 1.0 mL/min,
4.6.4. 2,20-Bis[(S)-4-tert-butyloxazolin-2-yl]-1,10-
diphenylsulfide 1d
Prepared according to the general procedure using 0.523 g
(1.10 mmol) 8d. The desired ligand was obtained as a colorless
oil (0.274 g, 57% yield). ½a D20
ꢁ
¼ ꢂ108:6 (c 0.3, CH2Cl2). 1H NMR
(300 MHz, CDCl3): d = 7.74 (d, J = 6.9 Hz, 2H), 7.21–7.32 (m, 6H),
4.24 (t, J = 9.3 Hz, 2H), 4.13 (t, J = 8.1 Hz, 2H), 4.02 (dd,
J1 = 10.2 Hz, J2 = 8.1 Hz, 2H), 0.91 (s, 18H). 13C NMR (75 MHz,
CDCl3): d = 162.7, 137.4, 132.5, 130.7, 130.2, 129.5, 126.4, 76.7,
68.6, 33.8, 25.8. IR (neat): 2953, 2901, 2868, 1654, 1477, 1353,
1246, 1097, 1037, 1024, 964, 901, 764, 737 cmꢂ1. HR-ESIMS: m/z
cacld for C26H33N2O2S (M+H): 437.22627. Found: 437.22545.
254 nm, tmajor = 7.8 min, tminor = 9.6 min).
½
a 2D0
ꢁ
¼ þ67:8 (c 0.7,
CH2Cl2, 85% ee). 1H NMR (300 MHz, CDCl3): d = 7.41 (d, J = 7.5 Hz,
2H), 7.23–7.34 (m, 6H), 7.09–7.12 (m, 2H), 6.85 (dd, J1 = 15.9 Hz,
J2 = 8.7 Hz, 1H), 6.59 (d, J = 15.9 Hz, 1H), 4.41 (dd, J1 = 8.4 Hz,
J2 = 3.6 Hz, 1H), 3.87 (d, J = 3.6 Hz, 1H), 3.11 (s, 3H), 3.09 (s, 3H).
13C NMR (75 MHz, CDCl3): d = 167.9, 167.0, 150.9, 137.9, 136.6,
132.8, 128.64, 128.56, 128.2, 127.8, 127.5, 126.5, 56.1, 53.0, 28.1,
28.0. IR (neat): 2957, 1676, 1449, 1422, 1377, 1290, 1115, 970,
4.7. General procedure for catalytic asymmetric allylic
alkylation
747, 695 cmꢂ1
. HR-ESIMS: m/z cacld for C21H21N2O2 (M+H):
349.15522. Found: 349.15507.
To
a
flame dried Schlenk tube, [Pd(
g
3-C3H5)Cl]2 (4.6 mg,
4.7.4. (S)-Diethyl 2-[(E)-1,3-bis(naphth-1-yl)prop-2-en-1-
yl]malonate 14
0.0125 mmol) and ligand 1d (13.1 mg, 0.03 mmol) were added un-
der argon, followed by addition of toluene (2.0 mL). The solution
was stirred at room temperature for 0.5 h. Then allyl acetate sub-
strate (0.5 mmol) was added, and the mixture was stirred for
10 min before the addition of nucleophile (1.5 mmol), BSA
(0.37 mL, 1.5 mmol) and anhydrous KOAc (10 mg, 0.10 mmol).
After being stirred for 24–120 h, water was added and the mixture
was extracted with EtOAc (20 mL), and the combined organic
phase was dried over anhydrous Na2SO4. The solvent was removed
in vacuo, and the residue was purified by flash chromatography.
The ee was determined by chiral HPLC on Daicel Chiracel IA or
AS-H column. For details, see supporting information.
Prepared according to the general procedure using (E)-1,3-di(1-
naphthyl)prop-2-en-1-yl acetate (0.176 g, 0.50 mmol), while the
reaction time was 36 h. The desired product was obtained as a col-
orless oil (221 mg, 98% yield). The ee was determined by chiral
HPLC on Daicel Chiracel IA column (n-hexane–isopropanol 85:15
V/V, 0.8 mL/min, 254 nm, tminor = 7.9 min, tmajor = 10.3 min).
½
a 2D0
ꢁ
¼ þ33:6 (c 0.8, CH2Cl2, 94% ee). 1H NMR (300 MHz, CDCl3):
d = 8.42 (d, J = 8.7 Hz, 1H), 7.96 (d, J = 7.5 Hz, 1H), 7.82 (d,
J = 8.1 Hz, 1H), 7.71–7.75 (m, 2H), 7.66 (d, J = 8.1 Hz, 1H), 7.29–
7.59 (m, 9H), 6.45 (dd, J1 = 15.6 Hz, J2 = 8.4 Hz, 1H), 5.34 (t,
J = 9.6 Hz, 1H), 4.29 (d, J = 10.8 Hz, 1H), 4.21 (qd, J1 = 7.2 Hz,
J2 = 2.1 Hz, 2H), 3.85 (q, J = 7.2 Hz, 2H), 1.19 (t, J = 7.2 Hz, 3H),
0.80 (t, J = 7.2 Hz, 3H). 13C NMR (75 MHz, CDCl3): d = 168.1,
167.3, 136.3, 134.5, 134.0, 133.4, 132.4, 131.4, 131.0, 129.5,
128.8, 128.3, 127.8, 127.6, 126.2, 125.9, 125.6, 125.4, 125.2,
124.4, 123.8, 123.6, 123.4, 61.6, 61.3, 57.6, 44.0, 14.0, 13.4. IR
(neat): 2986, 1753, 1730, 1394, 1368, 1280, 1250, 1177, 1154,
1031, 798, 777 cmꢂ1. HR-ESIMS: m/z cacld for C30H29O4 (M+H):
475.18853. Found: 475.18754.
4.7.1. (S)-Diethyl 2-[(E)-1,3-diphenylprop-2-en-1-yl]malonate
11
Prepared according to the general procedure using (E)-1,3-
diphenylprop-2-en-1-yl acetate (0.126 g, 0.50 mmol), while the
reaction time was 24 h. The desired product was obtained as color-
less oil (172 mg, 98% yield). The ee was determined by chiral HPLC
on Daicel Chiracel IA column (n-hexane–isopropanol 90:10 V/V,
0.5 mL/min,
254 nm,
tminor = 14.6 min,
tmajor = 17.7 min).
½
a 2D0
ꢁ
¼ ꢂ7:9 (c 2.3 g/100 mL, CH2Cl2, 91% ee). {Lit.17
½
a 2D5
ꢁ
¼ ꢂ17:2
4.7.5. (S)-Dimethyl 2-[(E)-1,3-bis(naphth-1-yl)prop-2-en-1-
yl]malonate 15
Prepared according to the general procedure using (E)-1,3-di(1-
naphthyl)prop-2-en-1-yl acetate (0.176 g, 0.50 mmol), while the
(c 1.02, CHCl3) 97% ee}. 1H NMR (300 MHz, CDCl3): d = 7.16–7.31
(m, 10H), 6.48 (d, J = 15.6 Hz, 1H), 6.34 (dd, J1 = 15.6 Hz,
J2 = 8.1 Hz, 1H), 4.27 (dd, J1 = 10.8 Hz, J2 = 8.7 Hz, 1H), 4.16 (q,